Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has released its quarterly report for the period ended March 31, 2025, revealing a mix of challenges and potential opportunities within the organization.
Here are key points extracted from the income statement and financial condition:
Total Expenses: In...